文献速递神经MR

高分级胶质瘤定量与定性MRI特征在遗传学特征及预后比较中的研究:聚焦G3胶质瘤

Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
PubMed 文献 · Korean J Radiol · 2020-09-10

该研究纳入76例病理确诊的WHO III级(G3)胶质瘤和155例胶质母细胞瘤(GBM)患者,评估治疗前脑MRI定性与定量特征(包括体积测量及nCBV、nCBF、nADC直方图参数)与肿瘤主要基因组特征及预后的关联。结果显示,IDH突变型G3胶质瘤较IDH野生型体积更大、nCBF更低、nADC更高;在IDH突变肿瘤中,IDHmut1p/19qdel较IDHmut1p/19qnondel有更高nCBV和更低nADC;IDHmut1p/19qdel预后最好,IDHwt预后最差;IDHwt G3胶质瘤与IDHwt GBM在PFS和影像特征上无显著差异。

要点

  • IDH突变型G3胶质瘤较IDH野生型体积更大(p=0.017)、nCBF更低(p=0.048)、nADC更高(p=0.007)。
  • IDHmut1p/19qdel型G3胶质瘤较IDHmut1p/19qnondel型nCBV更高(p=0.024)、nADC更低(p=0.002)。
  • G3胶质瘤中IDHmut1p/19qdel预后最好、IDHwt预后最差(p<0.001),PFS与nCBV和nCBF的95百分位值显著相关。

研究设计与样本

  • 研究纳入76例病理确诊的G3胶质瘤和155例GBM患者,均有治疗前脑MRI及肿瘤主要遗传学信息。
  • 评估定性与定量影像特征,包括体积测量和直方图参数如nCBV、nCBF和nADC。
  • G3胶质瘤按IDH突变和1p/19q状态分为三组:IDH突变伴1p/19q共缺失(IDHmut1p/19qdel)、IDH突变不伴1p/19q共缺失(IDHmut1p/19qnondel)和IDH野生型(IDHwt)。
  • 建立并验证了G3胶质瘤遗传学特征的预测模型(验证队列为独立队列)。
  • 比较G3胶质瘤的定量与定性影像参数及无进展生存期(PFS),进行生存分析;并比较IDHwt G3胶质瘤与GBM的影像参数和PFS。

关键影像表现/征象

  • IDHmut G3胶质瘤较IDHwt体积更大(p=0.017)、nCBF更低(p=0.048)、nADC更高(p=0.007)。
  • 在IDHmut肿瘤中,IDHmut1p/19qdel G3胶质瘤较IDHmut1p/19qnondel G3胶质瘤nCBV更高(p=0.024)、nADC更低(p=0.002)。
  • IDHwt G3胶质瘤与IDHwt GBM在PFS和影像特征上均无显著差异。

诊断标准与关键数值

  • G3胶质瘤中IDHmut1p/19qdel预后最好,IDHwt预后最差(p<0.001)。
  • G3胶质瘤中PFS与nCBV和nCBF的95百分位值显著相关。

临床应用与阅片要点

  • IDH突变型G3胶质瘤体积更大、nCBF更低、nADC更高,IDH野生型则相反。
  • IDHmut1p/19qdel型G3胶质瘤较IDHmut1p/19qnondel型nCBV更高、nADC更低,可提示1p/19q共缺失状态。
  • IDHwt G3胶质瘤的MRI特征和预后与IDHwt GBM相似,阅片时需注意其侵袭性可能接近GBM。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the association of MRI features with the major genomic profiles and prognosis of World Health Organization grade III (G3) gliomas compared with those of glioblastomas (GBMs).

MATERIALS AND METHODS: We enrolled 76 G3 glioma and 155 GBM patients with pathologically confirmed disease who had pretreatment brain MRI and major genetic information of tumors. Qualitative and quantitative imaging features, including volumetrics and histogram parameters, such as normalized cerebral blood volume (nCBV), cerebral blood flow (nCBF), and apparent diffusion coefficient (nADC) were evaluated. The G3 gliomas were divided into three groups for the analysis: with this isocitrate dehydrogenase (IDH)-mutation, IDH mutation and a chromosome arm 1p/19q-codeleted (IDHmut1p/19qdel), IDH mutation, 1p/19q-nondeleted (IDHmut1p/19qnondel), and IDH wildtype (IDHwt). A prediction model for the genetic profiles of G3 gliomas was developed and validated on a separate cohort. Both the quantitative and qualitative imaging parameters and progression-free survival (PFS) of G3 gliomas were compared and survival analysis was performed. Moreover, the imaging parameters and PFS between IDHwt G3 gliomas and GBMs were compared.

RESULTS: IDHmut G3 gliomas showed a larger volume (p = 0.017), lower nCBF (p = 0.048), and higher nADC (p = 0.007) than IDHwt. Between the IDHmut tumors, IDHmut1p/19qdel G3 gliomas had higher nCBV (p = 0.024) and lower nADC (p = 0.002) than IDHmut1p/19qnondel G3 gliomas. Moreover, IDHmut1p/19qdel tumors had the best prognosis and IDHwt tumors had the worst prognosis among G3 gliomas (p < 0.001). PFS was significantly associated with the 95th percentile values of nCBV and nCBF in G3 gliomas. There was no significant difference in neither PFS nor imaging features between IDHwt G3 gliomas and IDHwt GBMs.

CONCLUSION: We found significant differences in MRI features, including volumetrics, CBV, and ADC, in G3 gliomas, according to IDH mutation and 1p/19q codeletion status, which can be utilized for the prediction of genomic profiles and the prognosis of G3 glioma patients. The MRI signatures and prognosis of IDHwt G3 gliomas tend to follow those of IDHwt GBMs.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Hong EK, Choi SH, Shin DJ, et al. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas. Korean J Radiol. 2020. PMID: 32932560. doi:10.3348/kjr.2020.0011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。